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Patients with premature menopause constitute a group at high risk of
atherosclerotic vascular disease. To investigate this further, we measured se-
quential changes in plasma Ievelsof the soluble leukocyte adhesion molecule
P-selecfin (ELISA, R&Dsyetems; associated with platelet activity andathero-
genesis), von Willebrand factor (vWF: ELISA, DAKO; a marker of endothelial
dyafunetion),fibrinogen (CLAUSS), fibrin Ddimer (AGEN-ELISA; an index of
fibrin turnover and thrombogenesis), plasminogen activator inhibitor (PAI-1:
ELISA-Stage; an index of reduced fibrinolysis and increased thromlmgene-
sis), lipoprotein (a) (Lp(a): INCSTAR)and lipids in 22 pre-menopausal women
(mean age 43.0 years & 6.5) undergoing a (premature) aurgical menopause
following hysterectomyand bilateral oophracfomy,where oestrogen hormone
replacement therapy (HRT) was statted 6 weeks later.
Results:
Pre.hysterectomy 6 weeks 6 weeka
post-hysterectomy ~st-HRT
P-selsctin(median)n~ml 54S 560 390””
vWF(mesn)iU/dl 119 110 g4**
fibrinogen(mean)@l 2.97 3.03 3.10
D-dimer(median)n~ml 70 100 50
PAI-1(mean)rig/ml 26.6 21.2 16.3**
Lp(a)(median)m@dl 19.4 22.4* 20.6
cholesterol(mean)mmol?l 5.2 5.6* 5.4
triglycerides(mean)mmo!fl 1.3 1.9” 1.7*
There waa an increase in serum Lp(a), cholesterol and triglycerides fol-
lowing surgical menopause (paired t-teat ‘p < 0.01). Following HRT use,
there was a reduction in soluble P-selectin (pairad Wilcoxon test, “p -=0.05)
and plasma vWF and PAI-I levels (paired t-test, “’p < 0.05) compared to
bsaaline. Lp(a) and cholesterol levels post-HRT were not significantly dif-
ferent from prehysteraetomy levels. There were no significant changes in
plasma fibrinogen and D-dimer levels. Conclusion: HRT use results in a re-
duction insoluble P-aelectin, vWF and PAI-1, suggesting beneficial effects of
HRT uae on endothelial function, atherogeneais and thrombogenesis. This
is consistent with the beneficial effects of HRT in cardiovascular disease
prevention.
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Epidemiologic studies have demonstrated a poaitive association between
moderate alcohol consumption and a reduced overall morlality due largely
to a reduced risk of cardiovascular mortality. This association may be me-
diated through increaaed fibrinolysis as suggestad by alcohol-induced in-
creases in t-PA, resulting in increased fibrinolyfic activity (plasmin genera-
tion), thus decreasing the risk for thrombosis, CAD and Ml. This study will
determine whether alcohol can act directly on endogenous endothelial cell
(EC) surface-localized fibrinolytic components involved in plasmin genera-
tion, resulting in increased fibrinolysis. Fibrfnolytic activity was measured by
direct activation of cell-bound 1251-labeladGlu-plasminogen (Ping) and quan-
titstion of ‘251-plasmin M, 20-kDa light-chain formation, following reduced
SDS-PAGE/phosphorimaging autoradiography analysis. Confluent cultured
human umbilical vein ECS were preincubated (20 rein, 4QC)with alcohol
(0-0.1%), followed by incubation with 1251-labeledGlu-Pmg (2 KM, 20 rein,
4QC).Affer incubation (37QC,10 rein), samples were solubilized, reduced,
analyzed by SDS-PAGE and plasmin levels calculated. Endogenous activity
was doae-dependent, reached a maximum 15 to 16-fold increase at 0.05%
alcohol (82 vs. 1,440 pmol/well) and was completely inhibited by anti-t-PA
lgG. Similar responses were seen with cultured human saphenous vein and
porcine aortic ECS.These results indicste that alcohol consumed in moder-
ation may act as a oerdioprotectant agent by rapidly and directly increasing
t-PA-mediatad EC surface-localized fibrinolytic activity, thus decreasing the
risk for thrombosis, CAD and ML
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Background: High plasma homocysteine (HCY) is a risk factor foratheroscle-
rosis in end stage renal diaease (ESRD) and is inversely related to concen-
trations of B vitamins including folic acid.
Aims and Methods: Toasaesa the relationship between HCY and folate in
ESRD, ooneentrationsof both were measured in 97 men and 79 women, age
56.3 + 14.8yrswith ESRDroutinely supplemented with folicacid. Regression
coefficients and scatter plots were compared with healthy controls.
Resu/ta: In mmparison to controls, patients with ESRD had higher levels
of HCY (26.6 & 1.5 vs 10.1 + 1.7 vmo!fL, p < 0.01) and serum folate (56.5
+ 2.9 vs 15.6 + 1.7 nmol/L, p < 0.01), The lowest HCY levels in casea lay
within the upper normal range (see figure) but mrresponded to folate levels
far above controls.
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Conclusions: In ESRD, HCY is high and correlates negatively with folate.
Reduction may be possible but may require supplementation with far higher
doses of folic acid than those currently used.
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Hyperhomocysteinaemia is a reported risk factor for accelerated atheroscle-
rosis.Reducadactivityof 5,10-methylene tetrahydrofolate reductase (MTHFR)
and elevated plasma homocysteine levels may be aeen in individuals with
a thermolabile variant of MTHFR (t-MTHFR). Upto 17% of patients with
coronary disease are reported to express the thermolabile phenotype. We
prospectively evaluated the relationship between the genetic defect (MTHFR
nt677 C+ T, by PCR analysis) and coronay’ disease in 106 patients un-
dergoing diagnostic coronary angiography. Standard risk faetore were also
recorded. In the study population the presence of coronav disease was pos-
itively correlated with increasing age (p = 0.006), male sex (p < 0.001) and
tobacco consumption (p < 0.001). t-MTHFR atatus waa not predictive of the
presence of coronary diaease, nor of multivessel disease. Significant coro-
nary disease was present in 79% of normals (+/+), 71% of heterozygotes (+),
and 71Y0of homozygotes (–/–). In the 79 patients with coronary disease,
coronary occlusion and impaired left ventricular function were significantly
related to t-MTHFR status (p = 0.02 & p = 0.04, respectively). Coronary oc-
clusion was present in 34%, 54% and 80’YOin those who were normal (+/+),
heterozygous (+), and homozygous (–/–), respectively. The effect remains
after adjusting for sex, age, cigarette consumption, family history,cholesterol.
Conclusion: t-MTHFR mutation statua is predictive of corona~ occluaion in
patients with atherornatous coronary disease. Possession of this mutation
associated with t-MTHFR maybe a predictor of adverse prognosis in patienta
with coronaty disease.
